Tandlægeselskabet Colosseum Holbæk ApS: Financial statements 2024
CVR: 40750185
Tandlægeselskabet Colosseum Holbæk ApS (CVR 40750185) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 12,824,398 and a net result of DKK 778,362 compared with DKK 115,059 the year before. That is an increase of 49.1% compared with the year before. Equity amounted to DKK 939,018. The solvency ratio was 17.5%. The company had 14 employees in the financial year.
- Gross Profit
- 12,824,398 kr.
- Profit/Loss
- 778,362 kr.
- Equity
- 939,018 kr.
- Total Assets
- 5,374,330 kr.
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 12.8 mio. | 778 t. | 939 t. | 14 |
| 2023 | - | 8.6 mio. | 115 t. | 161 t. | 12 |
| 2022 | - | 7.4 mio. | -133 t. | 46 t. | 11 |
| 2021 | - | 7.5 mio. | 358 t. | 179 t. | 12 |
| 2020 | - | 6.7 mio. | -311 t. | -179 t. | 12 |
How creditworthy is Tandlægeselskabet Colosseum Holbæk ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Tandlægeselskabet Colosseum Holbæk ApS has published its annual report for 2023. Gross profit came to DKK 8,599,385, and the net result was DKK 115,059.
As of June 1, 2024, Mogens Juul Buskbjerg has joined the board of directors of Tandlægeselskabet Colosseum Holbæk ApS.
As of June 1, 2024, Viktoria Oceans has left the board of directors of Tandlægeselskabet Colosseum Holbæk ApS.
As of June 1, 2024, Mogens Juul Buskbjerg is registered as adm. dir. of Tandlægeselskabet Colosseum Holbæk ApS.
As of June 1, 2024, Viktoria Oceans has stepped down as adm. dir. of Tandlægeselskabet Colosseum Holbæk ApS.
About Tandlægeselskabet Colosseum Holbæk ApS
Tandlægeselskabet Colosseum Holbæk ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2019. The company is registered under the industry Tandlægers aktiviteter. The management consists of Yll Arifi. The company is owned by COLOSSEUMKLINIKKEN DANMARK ApS and Yll Arifi. In 2025, the company reported a gross profit of DKK 12,090,292 and a net result of DKK 1,065,601 compared with DKK 778,362 the year before. Equity amounted to DKK 2,004,620.
